Aspen Pharmacare Long Term Debt 2017-2023 | APNHY
Aspen Pharmacare long term debt from 2017 to 2023. Long term debt can be defined as the sum of all long term debt fields.
- Aspen Pharmacare long term debt for the quarter ending June 30, 2023 was $1.206B, a 35.82% decline year-over-year.
- Aspen Pharmacare long term debt for 2023 was $1.206B, a 73.14% increase from 2022.
- Aspen Pharmacare long term debt for 2022 was $0.696B, a 3914.85% increase from 2021.
- Aspen Pharmacare long term debt for 2021 was $0.017B, a 99.25% decline from 2020.
Aspen Pharmacare Annual Long Term Debt
(Millions of US $) |
| 2023 |
$1,206 |
| 2022 |
$696 |
| 2021 |
$17 |
| 2020 |
$2,320 |
| 2019 |
$2,800 |
| 2018 |
$3,649 |
| 2017 |
$2,124 |
| 2016 |
$2,269 |
| 2015 |
$ |
Aspen Pharmacare Quarterly Long Term Debt
(Millions of US $) |
| 2023-06-30 |
$1,206 |
| 2022-06-30 |
$696 |
| 2021-12-31 |
$1,294 |
| 2021-06-30 |
$17 |
| 2020-12-31 |
$1,878 |
| 2020-06-30 |
$2,320 |
| 2019-06-30 |
$2,800 |
| 2018-12-31 |
$3,670 |
| 2018-06-30 |
$3,649 |
| 2017-12-31 |
$2,168 |
| 2017-06-30 |
$2,124 |
| 2016-12-31 |
$2,563 |
| 2016-06-30 |
$2,269 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.574B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
